EUVIMEDEUVIMED entdecken
Open Access · CC0

Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis

Riya Ghosh, Garima Joshi, Nishith M Shrimali, Kanchan Bhardwaj, Tsewang Chorol, Tashi Thinlas, Parvaiz A Koul, Josef T Prchal, Prasenjit Guchhait iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Riya Ghosh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Manav Rachna International Institute of Research and Studies, Faridabad, India. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Hypoxia-Inducible Factor-Proline Dioxygenases, Interferons, Hypoxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Department of Biotechnology, Govt. of India, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously reported that Tibetan-specific variant of prolyl-hydroxylase-2 (PHD2) D4E;C127S protects highlanders from hypoxia-triggered pathologies by destabilizing hypoxia-inducible factor (HIF)-1α. Others have reported that stabilized HIF1α negatively regulates interferon (IFN)-regulating factor (IRF)-3 under hypoxia. We examined the role of PHD2 D4E;C127S variant in IFN synthesis in immune cells during viral infections. Primary monocytes and cells engineered to express the PHD2 D4E;C127S variant displayed protection against dengue virus (DENV)-2 infection by suppressing HIF1α, in turn promoting IRF-3 and IFNα/β synthesis in hypoxia (3% O 2 ) in vitro. However, under normoxia (21% O 2 ), these mutant cells increased reactive oxygen species (ROS) generation following DENV2 infection. Increased ROS then suppressed PHD2 D4E;C127S activity, reflected by reduced hydroxylation and concomitant stabilization of HIF1α, resulting in suppressed IFN synthesis and higher DENV2 replication. The PHD2 WT cells demonstrated the opposite trend. Our data further confirmed the inverse correlation between HIF1α and IFN pathways. CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing IFN-A/B and IRF-3/7/9 expression. HIF1α-depleted monocytes also showed a similar response to the infection. We extended our findings to COVID-19 infection. The CD4/CD8 T-cells collected from Tibetans with PHD2 D4E;C127S variant and exposed to SARS-CoV-2 infection showed elevated expression of IFN-γ in response to exposure to SARS-CoV-2 receptor-binding domain (RBD) peptide under hypoxia, and a lesser expression under normoxia. The study thus highlights a unique crosstalk of PHD2 D4E;C127S variant with HIF1α-IFN axis under environmental pO 2 in protecting or predisposing Tibetans to viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesInterferonsHypoxiaDengueHumansTibetDengue VirusMonocytes

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesHIF1A protein, humanInterferonsEGLN1 protein, human

Autor:innen und Institutionen

  • Manav Rachna International Institute of Research and Studies, Faridabad, India.
  • Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, India.
  • Sonam Nurboo Memorial Hospital, Leh-Ladakh, Jammu and Kashmir, India.
  • Department of Internal and Pulmonary Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Department of Medicine, University of Utah School of Medicine & Huntsman Cancer Center and George E. Wahlin Veteran's Administration Medical Center, Salt Lake City, Utah, United States of America.

ORCID-Profile: Prasenjit Guchhait

Förderung

  • Department of Biotechnology, Govt. of India
  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Ghosh, R., Joshi, G., Shrimali, N. M., Bhardwaj, K., Chorol, T., Thinlas, T., Koul, P. A., Prchal, J. T., & Guchhait, P. (2025). Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013296

Vancouver

Ghosh R, Joshi G, Shrimali NM, Bhardwaj K, Chorol T, Thinlas T, et al. Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013296

BibTeX
@article{Ghosh2025,
  author = {Ghosh, Riya and Joshi, Garima and Shrimali, Nishith M and Bhardwaj, Kanchan and Chorol, Tsewang and Thinlas, Tashi and Koul, Parvaiz A and Prchal, Josef T and Guchhait, Prasenjit},
  title = {Tibetan PHD2D4E;C127S variant protects from viral diseases in hypoxia, but predispose to infections in normoxia via HIFα:IFN axis},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013296}
}
Kostenlos starten →